Facebook Linkedin RSS Twitter Youtube
Home 2024

Crohn disease

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs
Drug Discovery

Lilly to Acquire Morphic for $3.2B, Adding Phase II IBD Programs

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells
News

Inflammatory Diseases Kindled When HDAC Proteins Act on Th17 Cells

CAR and Mesenchymal Stromal Cells Combine to Enhance Autoimmune Disease Immunotherapy
News

CAR and Mesenchymal Stromal Cells Combine to Enhance Autoimmune Disease Immunotherapy

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO
Drug Discovery

Abivax Advances Ulcerative Colitis Candidate with U.S. IPO

“Itch Cytokine” Contributes to Allergy via Neuroimmune Pathway
Featured

“Itch Cytokine” Contributes to Allergy via Neuroimmune Pathway

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt
Cancer

StockWatch: J&J Falls and Rises on Q1 Results, Leaked Data, Trial Halt

Genetic Variant Linked with Severe Manifestation of Crohn’s Disease
Featured

Genetic Variant Linked with Severe Manifestation of Crohn’s Disease

Norovirus Link with Crohn’s Disease May Point to New Therapeutic Strategies
Drug Discovery

Norovirus Link with Crohn’s Disease May Point to New Therapeutic Strategies

123...9Page 1 of 9
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.